Updated on 2026/05/25

Information

 

写真a

 
TAKASHIMA MASAMITSU
 
バナー付きURL
Organization
Kyushu University Hospital Department of Nephrology,Hypertension,and Strokology Assistant Professor
Title
Assistant Professor
Contact information
メールアドレス
Homepage

Research Areas

  • Life Science / Neuroscience-general

Degree

  • PhD ( 2023.3 Kyushu University )

Papers

  • <i>RNF213 </i>p.R4810K Variant and Intracranial Atherosclerosis: Increased Risk in Obese Variant Carriers Reviewed International journal

    Takashima, M; Kiyohara, T; Nakamura, K; Ozaki, Y; Yoshino, F; Hashimoto, G; Hidaka, M; Sahara, N; Irie, F; Wakisaka, Y; Matsuo, R; Kamouchi, M; Kitazono, T; Ago, T

    JOURNAL OF STROKE   28 ( 1 )   172 - 175   2026.1   ISSN:2287-6391 eISSN:2287-6405

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Journal of Stroke  

    DOI: 10.5853/jos.2025.02607

    Web of Science

    Scopus

    PubMed

  • Low-dose sodium-glucose cotransporter 2 inhibitor ameliorates ischemic brain injury in mice through pericyte protection without glucose-lowering effects Reviewed International journal

    Takashima, M; Nakamura, K; Kiyohara, T; Wakisaka, Y; Hidaka, M; Takaki, H; Yamanaka, K; Shibahara, T; Wakisaka, M; Ago, T; Kitazono, T

    COMMUNICATIONS BIOLOGY   5 ( 1 )   653   2022.7   eISSN:2399-3642

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Communications Biology  

    Antidiabetic sodium-glucose cotransporter 2 (SGLT2) inhibitors have attracted attention for their cardiorenal-protective properties beyond their glucose-lowering effect. However, their benefits in ischemic stroke remain controversial. Here we show the effects of luseogliflozin, a selective SGLT2 inhibitor, in acute ischemic stroke, using a permanent middle cerebral artery occlusion (pMCAO) model in non-diabetic mice. Pretreatment with low-dose luseogliflozin, which does not affect blood glucose levels, significantly attenuated infarct volume, blood-brain barrier disruption, and motor dysfunction after pMCAO. SGLT2 was expressed predominantly in brain pericytes and was upregulated in peri- and intra-infarct areas. Notably, luseogliflozin pretreatment reduced pericyte loss in ischemic areas. In cultured pericytes, luseogliflozin activated AMP-activated protein kinase α and increased mitochondrial transcription factor A expression and number of mitochondria, conferring resistance to oxygen-glucose deprivation. Collectively, pre-stroke inhibition of SGLT2 induces ischemic tolerance in brain pericytes independent of the glucose-lowering effect, contributing to the attenuation of ischemic brain injury.

    DOI: 10.1038/s42003-022-03605-4

    Web of Science

    Scopus

    PubMed

  • PDGFRβ-positive cell-mediated post-stroke remodeling of fibronectin and laminin α2 for tissue repair and functional recovery Reviewed International journal

    Shibahara, T; Nakamura, K; Wakisaka, Y; Shijo, M; Yamanaka, K; Takashima, M; Takaki, H; Hidaka, M; Kitazono, T; Ago, T

    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM   43 ( 4 )   518 - 530   2023.4   ISSN:0271-678X eISSN:1559-7016

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Journal of Cerebral Blood Flow and Metabolism  

    Post-stroke intra-infarct repair promotes peri-infarct neural reorganization leading to functional recovery. Herein, we examined the remodeling of extracellular matrix proteins (ECM) that constitute the intact basal membrane after permanent middle cerebral artery occlusion (pMCAO) in mice. Among ECM, collagen type IV remained localized on small vessel walls surrounding CD31-positive endothelial cells within infarct areas. Fibronectin was gradually deposited from peri-infarct areas to the ischemic core, in parallel with the accumulation of PDGFRβ-positive cells. Cultured PDGFRβ-positive pericytes produced fibronectin, which was enhanced by the treatment with PDGF-BB. Intra-infarct deposition of fibronectin was significantly attenuated in pericyte-deficient Pdgfrb<sup>+/−</sup> mice. Phagocytic activity of macrophages against myelin debris was significantly enhanced on fibronectin-coated dishes. In contrast, laminin α2, produced by GFAP- and aquaporin 4-positive astrocytes, accumulated strongly in the boundary of peri-infarct areas. Pericyte-conditioned medium increased the expression of laminin α2 in cultured astrocytes, partly through TGFβ1. Laminin α2 increased the differentiation of oligodendrocyte precursor cells into oligodendrocytes and the expression of myelin-associated proteins. Peri-infarct deposition of laminin α2 was significantly reduced in Pdgfrb<sup>+/−</sup> mice, with attenuated oligodendrogenesis in peri-infarct areas. Collectively, intra-infarct PDGFRβ-positive cells may orchestrate post-stroke remodeling of key ECM that create optimal environments promoting clearance of myelin debris and peri-infarct oligodendrogenesis.

    DOI: 10.1177/0271678X221145092

    Web of Science

    Scopus

    PubMed

  • Deletion of Nox4 enhances remyelination following cuprizone-induced demyelination by increasing phagocytic capacity of microglia and macrophages in mice Reviewed International journal

    Yamanaka, K; Nakamura, K; Shibahara, T; Takashima, M; Takaki, H; Hidaka, M; Komori, M; Yoshikawa, Y; Wakisaka, Y; Ago, T; Kitazono, T

    GLIA   71 ( 3 )   541 - 559   2023.3   ISSN:0894-1491 eISSN:1098-1136

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:GLIA  

    NOX4 is a major reactive oxygen species-producing enzyme that modulates cell stress responses. We here examined the effect of Nox4 deletion on demyelination–remyelination, the most common pathological change in the brain. We used a model of cuprizone (CPZ)-associated demyelination–remyelination in wild-type and Nox4-deficient (Nox4<sup>−/−</sup>) mice. While the CPZ-induced demyelination in the corpus callosum after 4 weeks of CPZ intoxication was slightly less pronounced in Nox4<sup>−/−</sup> mice than that in wild-type mice, remyelination following CPZ withdrawal was significantly enhanced in Nox4<sup>−/−</sup> mice with an increased accumulation of IBA1-positive microglia/macrophages in the demyelinating corpus callosum. Consistently, locomotor function, as assessed by the beam walking test, was significantly better during the remyelination phase in Nox4<sup>−/−</sup> mice. Nox4 deletion did not affect autonomous growth of primary-culture oligodendrocyte precursor cells. Although Nox4 expression was higher in cultured macrophages than in microglia, Nox4<sup>−/−</sup> microglia and macrophages both showed enhanced phagocytic capacity of myelin debris and produced increased amounts of trophic factors upon phagocytosis. The expression of trophic factors was higher, in parallel with the accumulation of IBA1-positive cells, in the corpus callosum in Nox4<sup>−/−</sup> mice than that in wild-type mice. Nox4 deletion suppressed phagocytosis-induced increase in mitochondrial membrane potential, enhancing phagocytic capacity of macrophages. Treatment with culture medium of Nox4<sup>−/−</sup> macrophages engulfing myelin debris, but not that of Nox4<sup>−/−</sup> astrocytes, enhanced cell growth and expression of myelin-associated proteins in cultured oligodendrocyte precursor cells. Collectively, Nox4 deletion promoted remyelination after CPZ-induced demyelination by enhancing microglia/macrophage-mediated clearance of myelin debris and the production of trophic factors leading to oligodendrogenesis.

    DOI: 10.1002/glia.24292

    Web of Science

    Scopus

    PubMed

Presentations

▼display all

MISC

Research Projects

  • Development of a Novel Therapeutic Strategy for Vascular Dementia Targeting SGLT2 in Pericytes

    Grant number:23K19593  2023.8 - 2025.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Research Activity Start-up

    Takashima Masamitsu

      More details

    Grant type:Scientific research funding

    In this study, we investigated whether SGLT2 inhibitors contribute to the preservation of pericytes and the neurovascular unit (NVU) in a mouse model of vascular dementia induced by chronic cerebral hypoperfusion. While we analyzed the expression changes of SGLT2 in this model, consistent findings in terms of cerebral blood flow reduction, white matter injury, and neurological dysfunction were not obtained, indicating challenges in reproducibility. We are currently re-evaluating the experimental conditions to establish a more stable model.
    Meanwhile, we successfully generated pericyte-specific SGLT2 conditional knockout (cKO) mice using the PDGFRβ promoter (Pdgfrb-P2A-CreERT2; Slc5a2fl/fl). Moving forward, we plan to utilize this cKO model to investigate the impact of SGLT2 loss in pericytes under appropriate cerebral ischemia models, focusing on demyelination, blood-brain barrier (BBB) disruption, behavioral abnormalities, and mechanisms of tissue repair.

    CiNii Research